BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26397898)

  • 21. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.
    Jansen AH; van Hal M; Op den Kelder IC; Meier RT; de Ruiter AA; Schut MH; Smith DL; Grit C; Brouwer N; Kamphuis W; Boddeke HW; den Dunnen WF; van Roon WM; Bates GP; Hol EM; Reits EA
    Glia; 2017 Jan; 65(1):50-61. PubMed ID: 27615381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Huntington's Disease and Mitochondria.
    Jodeiri Farshbaf M; Ghaedi K
    Neurotox Res; 2017 Oct; 32(3):518-529. PubMed ID: 28639241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choosing and using Drosophila models to characterize modifiers of Huntington's disease.
    Green EW; Giorgini F
    Biochem Soc Trans; 2012 Aug; 40(4):739-45. PubMed ID: 22817726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ku70 alleviates neurodegeneration in Drosophila models of Huntington's disease.
    Tamura T; Sone M; Iwatsubo T; Tagawa K; Wanker EE; Okazawa H
    PLoS One; 2011; 6(11):e27408. PubMed ID: 22096569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mHTT Seeding Activity: A Marker of Disease Progression and Neurotoxicity in Models of Huntington's Disease.
    Ast A; Buntru A; Schindler F; Hasenkopf R; Schulz A; Brusendorf L; Klockmeier K; Grelle G; McMahon B; Niederlechner H; Jansen I; Diez L; Edel J; Boeddrich A; Franklin SA; Baldo B; Schnoegl S; Kunz S; Purfürst B; Gaertner A; Kampinga HH; Morton AJ; Petersén Å; Kirstein J; Bates GP; Wanker EE
    Mol Cell; 2018 Sep; 71(5):675-688.e6. PubMed ID: 30193095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AUTEN-67 (Autophagy Enhancer-67) Hampers the Progression of Neurodegenerative Symptoms in a Drosophila model of Huntington's Disease.
    Billes V; Kovács T; Hotzi B; Manzéger A; Tagscherer K; Komlós M; Tarnóci A; Pádár Z; Erdős A; Bjelik A; Legradi A; Gulya K; Gulyás B; Vellai T
    J Huntingtons Dis; 2016 May; 5(2):133-47. PubMed ID: 27163946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila model.
    Besson MT; Alegría K; Garrido-Gerter P; Barros LF; Liévens JC
    PLoS One; 2015; 10(3):e0118765. PubMed ID: 25761110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.
    Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L
    Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering the key mechanisms leading to alteration of lipid metabolism in Drosophila model of Huntington's disease.
    Singh A; Agrawal N
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166127. PubMed ID: 33722743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
    Oliveira JM
    J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant Huntingtin Disrupts the Nuclear Pore Complex.
    Grima JC; Daigle JG; Arbez N; Cunningham KC; Zhang K; Ochaba J; Geater C; Morozko E; Stocksdale J; Glatzer JC; Pham JT; Ahmed I; Peng Q; Wadhwa H; Pletnikova O; Troncoso JC; Duan W; Snyder SH; Ranum LPW; Thompson LM; Lloyd TE; Ross CA; Rothstein JD
    Neuron; 2017 Apr; 94(1):93-107.e6. PubMed ID: 28384479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ataxin2 functions via CrebA to mediate Huntingtin toxicity in circadian clock neurons.
    Xu F; Kula-Eversole E; Iwanaszko M; Lim C; Allada R
    PLoS Genet; 2019 Oct; 15(10):e1008356. PubMed ID: 31593562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PINK1-induced mitophagy promotes neuroprotection in Huntington's disease.
    Khalil B; El Fissi N; Aouane A; Cabirol-Pol MJ; Rival T; Liévens JC
    Cell Death Dis; 2015 Jan; 6(1):e1617. PubMed ID: 25611391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of naturally occurring huntingtin fragments in Drosophila points to exon 1 as the most pathogenic species in Huntington's disease.
    Barbaro BA; Lukacsovich T; Agrawal N; Burke J; Bornemann DJ; Purcell JM; Worthge SA; Caricasole A; Weiss A; Song W; Morozova OA; Colby DW; Marsh JL
    Hum Mol Genet; 2015 Feb; 24(4):913-25. PubMed ID: 25305076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylene blue rescues heart defects in a Drosophila model of Friedreich's ataxia.
    Tricoire H; Palandri A; Bourdais A; Camadro JM; Monnier V
    Hum Mol Genet; 2014 Feb; 23(4):968-79. PubMed ID: 24105471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.
    Li XJ; Zhang YY; Fu YH; Zhang H; Li HX; Li QF; Li HL; Tan RK; Jiang CX; Jiang W; Li ZX; Luo C; Lu BX; Dang YJ
    Acta Pharmacol Sin; 2021 Oct; 42(10):1556-1566. PubMed ID: 33495516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington's disease model.
    Veldman MB; Rios-Galdamez Y; Lu XH; Gu X; Qin W; Li S; Yang XW; Lin S
    Mol Neurodegener; 2015 Dec; 10():67. PubMed ID: 26645399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
    Ban JJ; Chung JY; Lee M; Im W; Kim M
    Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.